Gender and liver fibrosis in chronic hepatitis: the role of iron status

Aliment Pharmacol Ther. 2005 Jun 15;21(12):1445-51. doi: 10.1111/j.1365-2036.2005.02517.x.

Abstract

Background: The role of gender in the progression of fibrosis in chronic hepatitis C is still under investigation.

Aim: To investigate whether gender affects the progression of liver disease and/or hides other risk factors.

Methods: A prospective series of 121 consecutive patients with chronic hepatitis C underwent liver biopsy. Grading and staging for chronic hepatitis were each evaluated according to Ishak's classification.

Results: In univariate and multivariate analysis on the whole group of patients, male gender was not associated either with significant liver fibrosis (Ishak's score > 2) or with cirrhosis (Ishak's score > 4). On the contrary, in univariate analysis on patients aged < or = 50 years, male gender was nearly significantly (P = 0.06) predictive of liver fibrosis, whereas it was not in patients > 50 years. Hepatic iron grading, along with age, was an independent factor associated with fibrosis. Moreover, the values of all the variables which describe iron status were significantly higher in males aged < or = 50 years in comparison with females of the same age.

Conclusions: In chronic hepatitis C, male gender may be predictive of liver fibrosis only in patients aged < or = 50 years. Among fibrogenetic factors hidden by gender, iron status could play a major role.

MeSH terms

  • Adult
  • Aged
  • Biopsy / methods
  • Disease Progression
  • Female
  • Ferritins / blood
  • Hepatitis C, Chronic / blood*
  • Hepatitis C, Chronic / pathology
  • Humans
  • Iron / blood*
  • Liver Cirrhosis / blood
  • Liver Cirrhosis / etiology*
  • Liver Cirrhosis / pathology
  • Male
  • Middle Aged
  • Prospective Studies
  • Transferrin / analysis

Substances

  • Transferrin
  • Ferritins
  • Iron